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ABSTRACT: A series of novel α-furfuryl-2-alkylaminophospho-
nates have been efficiently synthesized from the one-pot three-
component classical Kabachnik−Fields reaction in a green
chemical approach by addition of an in situ generated
dialkylphosphite to Schiff’s base of aldehydes and amines by
using environmental and eco-friendly silica gel supported iodine as
a catalyst by microwave irradiation. The advantage of this protocol
is simplicity in experimental procedures and products were
resulted in high isolated yields. The synthesized α-furfuryl-2-
alkylaminophosphonates were screened to in vitro antioxidant and
plant growth regulatory activities and some are found to be potent with antioxidant and plant growth regulatory activities. These in
vitro studies have been further supported by ADMET (absorption, distribution, metabolism, excretion, and toxicity), quantitative
structure−activity relationship, molecular docking, and bioactivity studies and identified that they were potentially bound to the
GLN340 amino acid residue in chain C of 1DNU protein and TYR597 amino acid residue in chain A of 4M7E protein, causing
potential exhibition of antioxidant and plant growth regulatory activities. Eventually, title compounds are identified as good blood−
brain barrier (BBB)-penetrable compounds and are considered as proficient central nervous system active and neuroprotective
antioxidant agents as the neuroprotective property is determined with BBB penetration thresholds.
1. INTRODUCTION
Organophosphorus chemistry research bestowed an elegant
locus to α-aminophosphonates as they have exhilarated with
potential antioxidant,1 antifungal,2 antibacterial,3 antidiabetic,4
anticancer,5 antiviral,6 antitumor,7 cytotoxic,8 antiproliferative,9
antibiotic,10 antithrombotic,11 peptidomimetic,12 catalytic anti-
bodies hapten,13 neuroactive enzyme inhibiting, and anti-bone
resorption14 activities. As they are tetrahedral transition-state
mimics, they are identified as HIV protease,15 synthase,16
serine hydrolase,17 and UDP-galactopyranose mutase18 inhib-
itors. They have also been identified as surrogates of both
natural and synthetic α-amino acids19 as constituted with
significant motifs in medicine. In agriculture, phosphorus is
identified as an essential element20,21 and is widely used in the
production of crop fertilizers. They find their use as
insecticides,21 plant growth regulators,22−24 herbicides,25
pesticides,26 fungicides,27 and in photosynthesis as ADP and
ATP. In the industry, they are used as additive polymers,28
surfactants,29 lubricants,29 surface treaters on metals,30 and
flame retardants.31 In organic chemistry,32 they have been used
as catalysts33 in coupling34 and complex reactions35 and also as
catalytic promoters.36 Many aminophosphonic acids/peptides/
esters from both synthetic and natural origin have displayed an
extensive array of biological activities.37 They act as substrates
in the synthesis and development of impending drugs against
various metabolic disorders.38
Owing to these, the synthesis of α-aminophosphonates had
grown more inquisitiveness in medicinal chemistry researchers
to study their structure−activity relationship and to design
some more potential libraries to the existing repositories.
Although a number of synthetic methodologies have been
reported to construct bioactive α-aminophosphonates,39−42
the nucleophilic phosphite addition to Schiff’s base is the
utmost prevailing and modest method. Here, certain active
catalysts such as titanium dioxide, boric acid, sulfonic acid
functionalized ionic liquid, nanoporous AlSBA-15,43 Magnetic
BaFe12O19/Al2O3,
44 and silica sulfuric acid45 are used with
conventional heating, sonication, microwave irradiation in
organic solvents,46 and even with simple grinding. Among
them, reactions stimulated with ultrasonic/microwave irradi-
ation led to the specific attention as these energizing
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techniques advance the reaction and complete it in less time
under trivial conditions and produces high yields and also
more pronounced scientifically. Concerning the vitality of
furfuryl and tetrahydrofurfuryl groups in pharmaceuticals,
fibers, and perfumes,47−51 one-pot microwave Kabachnik−
Fields synthesis of some novel and structurally diversified α-
furfuryl-2-ethyl aminophosphonates (5a−j) has been designed
through the reaction of aryl aldehydes, furfurylamine, and
dialkyl phosphonates (Scheme 1). The synthesized α-furfuryl-
2-alkylaminophosphonates were structurally confirmed by
physical characterization and spectral studies, and their
antioxidant and plant growth regulatory activities have been
evaluated by in silico and in vitro methods. Eventually, herein
we describe the microwave-supported synthesis, spectral and
physical characterization, and biological activity evaluation of
novel furfurylamine-based α-aminophosphonates. The addi-
tional studies such as molecular docking, quantitative
structure−activity relationship (QSAR), and ADMET (ab-
sorption, distribution, metabolism, excretion, and toxicity)
performed to study their bioactivity properties infer that the
bioactive proficiency of 5a−j has been administrated through a
stereogenic α-carbon’s configuration bonded to phosphorus.
2. RESULTS AND DISCUSSION
2.1. Chemistry. Synthesis of diethyl ((((furan-2-ylmethyl)-
amino) (4-hydroxy-3-methoxyphenyl)methyl) phosphonate)
(5a) has been accomplished by two different reaction pathways
A and B. Path A involves a straight one-pot and three-
component, SiO2−I2-catalyzed Kabachnik−Fields reaction of
vanillin (2a), furfurylamine (1), and diethylphosphite (3a)
promoted by microwave irradiation. In path B, the reaction is
carried out through the addition of diethylphosphite (3a) to
the vanillin-derived Schiff base, vanillinidene-furfurylamine (4)
(Scheme 1); by following the same procedure, the remaining
analogues of the series (5b−j) have been synthesized.
2.1.1. Optimization of Reaction Conditions for the
Synthesis of 5a. Both reactions were run under microwave
irradiation at different conditions and observed that best
product yields were obtained in both the pathways at 40 °C
and 600 W (Table 1). Among the two reaction pathways,
better product yields were obtained in path A in less time
because of the synergic formation of Schiff’s base from vanillin,
furfurylamine, and addition of phosphite to it. However, in
path B, water formed during the formation of imine hydrolyzes
the imine back to aldehyde that results in lower yields. We
observed that the reaction goes slowly and takes 6h to
complete without any catalyst. When the reaction was
conducted with different catalysts such as Al2O3, SiO2,
Al(OTf)3, and BF3·Et2O, moderate product yields (35−45%)
were obtained. When the reaction was conducted in 10 mol %
of SiO2−I2, a great increase in the rate of reaction yields in
lesser times takes place. At the outset, it was thought that
SiO2−I2 was acquainted for catalytic support; besides, kinetic
studies have revealed that it enhances the rate of reaction
because of its acidic characteristic and ease of binding of
silicone with several atoms of the substrates. Recently, several
research groups have utilized some silica-supported catalysts
such as SiO2−CeCl2 and SiO2−ZnCl252 effectively to
synthesize α-amino/carbamoyl/carbamothioyl phosphonates.
In addition, iodine was used as a catalyst owing to its
abundant availability and low cost, ease of handling, stability,
and use in numerous chemical transformations.53,54 Further,
the catalyst mixture SiO2−I2 was prepared from iodine and
silica gel (100−200 mesh) in a 2:1 ratio. It worked as a
heterogeneous catalyst and conveniently handled and sepa-
rated from the reaction mixture through filtration for reuse and
is environment-friendly. To our best knowledge, the SiO2−I2
catalyst has not been reported to synthesize α-amino-
phosphonates, and hence, we have explored the one-pot and
Scheme 1. Synthesis of α-Furfuryl-2-alkylaminophosphonates (5a−j)











25 100 ̲ 60 10.24
25 200 ̲ 60 12.49
25 300 ̲ 60 15.17
25 400 ̲ 60 20.66
25 500 ̲ 60 25.48
25 600 ̲ 60 32.59
25 700 ̲ 60 32.38
25 800 ̲ 60 20.27
30 600 ̲ 60 32.69
40 600 ̲ 60 35.74
50 600 ̲ 60 35.93
60 600 ̲ 60 25.87
40 600 Al2O3 45 51.79
40 600 SiO2 42 66.30
40 600 Al(OTf)3 40 70.52
40 600 nano Al2O3 43 57.95
40 600 BF3EtO 40 63.41
40 600 I2 35 76.54
40 600 SiO2−I2 20 92.29
aReaction conditions: diethyl phosphite (3a), vanillin-derived Schiff
base (4), and SiO2−I2 as the catalyst. bIsolated yield.
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three-component Kabachnik−Fields synthesis of α-furfuryl-2-
alkylamino-phosphonates under heterogeneous catalytic action
of SiO2−I2 in association with solvent-free, microwave
irradiation conditions.
Hence, the finest conditions for reacting 2.0 mmol of
aldehyde (2) and furfurylamine (1) with 2.1 mmol of
dialkylphosphite (3) and 10 mol % of SiO2−I2 under
microwave irradiation and neat conditions have accomplished
and produced 5a−j in 83−92% yields (Table 2). It is observed
that this reaction method is applicable to a wide range of
aromatic aldehydes (electron-rich as well as electron-deficient)
and diethyl and dimethyl phosphites and that the reactions
proceed smoothly in 20−30 min and produced 5a−j in
excellent isolated yields. Eventually, it is noticed that the effect
of electron-withdrawing groups on the carbonyl compound
decreases the product yield and also increases the reaction
time, while the effect of electron-releasing groups on carbonyl
compound increases the product yield and decreases the
reaction time.
2.1.2. Plausible Reaction Mechanism for the Synthesis of
5a−j. Obviously, this reaction is a multistep procedure with
the transition state having a quite complex mechanism (Figure
1). In fact, in the first step, the catalyst has greatly promoted
the reaction by the virtue of acidic nature of silicon, is well
influenced by iodine by withdrawing electrons from silica, and
activates electrophilically the carbonyl carbon of the aldehyde
(2), which facilitates nucleophilic substitution by the amine
(1) to form the imine (4).
Because its formation is a reversible process, it is trapped
immediately by the catalyst as a four-membered imine−
phosphite−SiO2−I2 complex transition state (4ts). Formation
of 4ts not only prevents hydrolysis of the imine substrate (4)
to the amine (1) and aldehyde (2) by water formed during the
condensation of amine (1) and aldehyde that also force the
reaction forward. The SiO2−I2 catalyst coordinates to the
nitrogen atom of 4ts renders it more electron rich by attracting
the electron density of imino bond and facilitates concerted
break-up of 4ts in such a way as to lead to the nucleophilic
addition of phosphino phosphorus to the iminocarbon atom
and electrophilic addition of hydrogen to the iminonitrogen
atom to form α-aminophosphonate (5) with simultaneous
release of the catalyst.
2.2. Antioxidant Activity. The title compounds were
screened for in vitro plant growth and antioxidant activities and
supported by molecular docking studies. Compounds which
inhibit the oxidation are known to be antioxidants. If oxidation
takes place, then there is a chance of formation of free radicals,
which leads to chain reactions that may damage the active cells.
Hence, the main aim of the antioxidants is to inhibit generation
of free radicals, thereby protecting the active cells.55−58 To
evaluate the capacity of antioxidants, different types of
methods are developed, and among them, 1,1-diphenyl-2-
picrylhydrazyl (DPPH) and H2O2 methods are more popular
and effective. Hence, the synthesized novel α-furfuryl-2-
ethylaminophosphonates (5a−j) are screened for antioxidant
activity by these methods.
2.2.1. DPPH Radical Scavenging Assay. Compounds 5a−j
were subjected to free radical scavenging in vitro by the DPPH
radical assay;59 the IC50 value denotes the concentration of the
compound that inhibits 50% process of oxidation and is
obtained by plotting the concentration versus percentage of
inhibition graph and the obtained IC50 values shown against
their compounds (Figure 2). Among the synthesized
compounds 5a−j, 5e (IC50 = 35.23) showed higher bioactivity
compared to standard ascorbic acid (IC50 = 39.42). Also, 5c
(38.03) and 5i (38.72) showed good results in comparison to
ascorbic acid. Perhaps their significant activities are due to the
presence of electron-donating methoxy (−OCH3) and hydroxy
(−OH) substitutions in 5c, 5i at meta and para position,
respectively. In 5e, the two methoxy groups at the meta
position being less conjugated than the methoxy group located
at the para position delivers additional electron density to
Table 2. Reaction Time and Yield of the Products 5a−j











Figure 1. Mechanism for SiO2−I2-catalyzed synthesis.
Figure 2. DPPH radical scavenging activity of 5a−j.
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overcome oxidation. The identical process in hydroxyl group
present in 5c and 5i, but which are less compared to methoxy
group, hydroxyl group and hence they have shown less
antioxidant activity than 5e. Furthermore, the presence of
electron-withdrawing groups in 5f (fluorine at the ortho
position and bromine at the meta position) decreases the
availability of electrons and is responsible for the lower activity.
2.2.2. H2O2 Radical Scavenging Assay. In practice, the
hydroxyl free radical scavenging assay of 5a−j has been
performed by deoxyribose method60 and was referenced to
ascorbic acid standard. In H2O2 radical scavenging assay, the
compound 5e (IC50 = 35.38) exhibited noteworthy activity
than the standard ascorbic acid (39.57), whereas compounds
5c (37.03) and 5i (38.72) exhibit moderate activities (Figure
3). Here also, the same structure−activity has been observed
among the series of compounds as noticed in the DPPH
radical scavenging assay. The results obtained from DPPH and
H2O2 free radical scavenging assays followed the linear
correlation and is comparable to each other. It is not necessary
that the OH group alone shows antioxidant activity. The
concept of electron donor and acceptor also plays a very
important role in the redox reactions. Therefore, any functional
group which is capable of donating electrons may act as a good
antioxidant. Among the synthesized title compounds, 5c, 5e,
and 5i showed relatively higher antioxidant activity potentiality
compared to standard ascorbic acid.
2.3. Plant Growth Activity. As organophosphorus
compounds are bioactive toward both animals and plants
and in such aminophosphonates are comparatively more
potent than glyphosate in terms of biological activity. It is
analyzed and identified that the biological activity of title
compounds intensely correlates with the lipophilic character-
istic of Trakephon and hence also resembles the plant growth
regulatory activity.61 Therefore, it is precisely credible that the
action of title compounds is linked with distracting plant
membrane’s function as proposed by many researchers. Based
on this notion, we have analyzed the effect of prepared α-
furfuryl-2-ethylaminophosphonates (5a−j) differentiated by
the nature of groups substituted on the phosphoryl phosphorus
and carbonyl carbon atoms and hence indicating diverse
polarity and hydrophobicity properties. Their plant growth
regulatory activity was tested on roots and shoots of aquatic
plant sorghum bicolor, using the technique of Smith and
Fowden.62
The results demonstrated that all the compounds (5a−j)
clearly influenced the growth of the plant roots as well as
shoots, but their effect on shoots is slightly less than that on
the roots. Compound 5c at 100 ppm showed highest root
length (7.06 cm), and compound 5e showed highest shoot
length (1.96 cm). Further the point of structure−activity
relationships, compounds substituted with electron-releasing
groups in the aromatic ring (5c, 5f, and 5j) promoted growth,
while those substituted with electron-withdrawing groups (5f)
inhibit the growth of the root. However, in the case of 5d and
5j, the presence of both electron-withdrawing and hydroxyl
groups showed moderate results. In the case of effect on shoot
lengths, all the compounds showed mostly equal effect. With
respect to the effect of concentration of the compound in
solution, plant growth also increases with the increase of
concentration of the compound. The results are represented in
Figure 4.
2.4. Molecular Docking Studies. The in vitro DPPH and
H2O2 radical scavenging activity and plant growth regulatory
activity of 5a−j have been supported by their binding
potentialities against the considered enzymatic protein chains
as revealed based on molecular docking studies. Here, the
molecular docking was executed for the structures of 5a−j
against the target protein receptors in chain C of 1DNU
(human myeloperoxidase−thiocyanate complex) protein and
chain A of 4M7E (BL-induced activation of the BRI1−BAK1
complex) protein, respectively, for the antioxidant and plant
growth regulatory activities to study their protein−ligand
binding interactions.
The potential binding modes of amino acid residues against
hydrogen bond acceptor and donor atoms of 5a−j and their
docking poses are presented in Tables 3−6. The binding
specificity of 5a−j with chain C (containing 466 amino acids)
Figure 3. H2O2 radical scavenging activity of 5a−j.
Figure 4. Plant growth regulatory activity of compounds 5a−j.
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of 1DNU (myeloperoxidase) protein has confirmed their
antioxidant potentiality as they were intensely bound with the
glutamine amino acid residue (GLN340) located at the 340
position of the amino acid series in the chain. This assures the
core interaction of synthesized compounds at the central
position of chain C, which is a valid consideration to support
antioxidant activity in vitro.
Remarkably, they were bound to GLN340 with a binding
energy of −9.2938 to −7.7212 kcal/mol with a rational bond
length of 1.9604−2.4743 Å in forming hydrogen bonds.
Profoundly, compounds 5a−j formed hydrogen bonding with
Table 3. Potential Protein−Ligand Interactions of 5a−j with Chain C of Protein 1DNU at GLN340 Amino Acid Residuea
aDocking poses of 5a−j, GLN340 in chain C of 1DNU protein and chain C of 1DNU protein (in ordertop left to bottom right).



















5a 4 1 −8.2531 1 1 1 ligand(PO)···(HN)
GLN340
2.4025 donor
5b 1 4 −9.2938 1 1 1 ligand(PO)···(HN)
GLN340
2.4223 donor
5c 0 0 −8.2422 1 1 1 ligand(PO)···(HN)
GLN340
2.3590 donor
5d 5 5 −8.6906 1 1 1 ligand(PO)···(HN)
GLN340
2.1219 donor
5e 4 3 −9.2858 1 1 1 ligand(PO)···(HN)
GLN340
2.3019 donor
5f 19 0 −8.0713 1 1 1 ligand[PO]···(HN)
GLN340
2.4743 donor
5g 0 0 −7.7212 1 1 1 ligand[PO]···(HN)
GLN340
2.3626 donor
5h 0 1 −8.2572 1 1 1 ligand(PO)···(HN)
GLN340
2.0139 donor
5i 0 11 −8.3254 1 1 1 ligand(PO)···(HN)
GLN340
1.9604 donor
5j 0 1 −8.4110 1 1 1 ligand(PO)···(HN)
GLN340
2.3885 donor
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GLN340 as an oxygen atom of the phosphoryl group has been
strongly bound to an amino hydrogen atom of the amide bond
present on the glutamine; hence, here the title compounds act
as the electron cloud donors in forming the hydrogen bond.
Similarly, the binding specificity of 5a−j with chain A
(containing 767 amino acids) of 4M7E (brassinosteroid
insensitive 1) protein has confirmed their plant growth
regulatory activity as they were intensely bound with tyrosine
amino acid residue (TYR597) located at the 597 position of
the amino acid series in the chain. This assures the core
interaction of synthesized compounds at central position of
chain A, which is a valid consideration to support plant growth
Table 5. Potential Protein−Ligand Interactions of 5a−j with Chain A of Protein 4M7E at TYR597 Amino Acid Residuea
aDocking poses of 5a−j, TYR597 in chain A of 4M7E protein and chain A of 4M7E protein (in ordertop left to bottom right).



















5a 2 1 −8.0654 1 1 1 ligand(P−C(H)−NH)···
(O−H)TYR597
1.9397 acceptor
5b 33 1 −8.1484 1 1 1 ligand(P−C(H)−NH)···
(O−H)TYR597
1.9236 acceptor
5c 0 0 −7.9312 1 1 1 ligand(P−C(H)−NH)···
(O−H)TYR597
2.1007 acceptor
5d 6 6 −7.9150 1 1 1 ligand(P−C(H)−NH)···
(O−H)TYR597
2.3359 acceptor
5e 20 1 −7.8425 1 1 1 ligand(P−C(H)−NH)···
(O−H)TYR597
2.7589 acceptor
5f 40 0 −7.6491 1 1 1 ligand(P−C(H)−NH)···
(O−H)TYR597
2.0703 acceptor
5g 1 3 −7.6353 1 1 1 ligand(P−C(H)−NH)···
(O−H)TYR597
2.3484 acceptor
5h 2 1 −7.8134 1 1 1 ligand(P−C(H)−NH)···
(O−H)TYR597
2.3462 acceptor
5i 21 2 −7.9364 1 1 1 ligand(P−C(H)−NH)···
(O−H)TYR597
2.3557 acceptor
5j 22 1 −7.3909 1 1 1 ligand(P−C(H)−NH)···
(O−H)TYR597
2.2885 acceptor
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regulatory activity. Remarkably, they were bound to TYR597
with a binding energy of −8.1484 to −7.3909 kcal/mol with a
rational bond length of 1.9397−2.7589 Å in forming hydrogen
bonds. Profoundly, compounds 5a−j formed hydrogen
bonding with TYR597 as the amino hydrogen atom of the
α-aminophosphoryl group has been strongly bound to the
phenolic oxygen atom present on the tyrosine; hence, here the
compounds 5a−j act as electron cloud acceptors in forming
the hydrogen bond. This investigation unveils that GLN340
and TYR597 amino acids are strongly bound to 5a−j and are
act as donors and acceptors, respectively, and responsible for
the predicted in vitro activities.
2.5. ADMET Properties. The analysis of ADMET profiles
for a library of molecules under scrutiny helps to figure out the
physicochemical collaborations and evaluate their druglikeness
properties. This sort of high-throughput screening assists in
characterizing a lead one out of a large group in the captivated
field of a target.63 This critical investigation had supported in
predicting the pharmacokinetic effects of 5a−j and to disclose
the druglikeness properties. Among the ADMET properties,
the human intestinal absorption designates transporting of the
effective composites to the target cell tissues via blood stream
and sustains their mutual interaction. During this the oral
administration of a compound under study, its degree of
absorption has been taken into account, which depends on its
intrinsic bioavailability characteristics. In turnout, the absorbed
quantity of the analyte is distributed to the muscles and then to
other organs in self-circulation mode through extracellular
sites. Then, the distribution of analyte drops down its plasma
concentration autonomously and then metabolized; from
there, such metabolites will be dispersed to the target sites
by enzymatic redox reactions. In pharmacological perspectives,
potentially distributed metabolites will work competently for
cellular organisms, and on the other side, the inactive
metabolites deactivate the controlled entity and moderate its
possible effect in vivo; finally, the inert metabolites are
inevitably emitted by kidneys. The analysis of the acquired
ADMET profiles (Table 7) of 5a−j infers us about the in vivo
blood−brain barrier (BBB) penetration potentiality ratio
which is operational in the range of 0.4518−2.5729 and
authorizes their high central nervous system (CNS) signifi-
cance and commends their greater permeability for its
distribution in vivo. It is strengthened on the source that the
in vitro Caco-2 cell permeability property is effective within
16.1225 to 21.7231 nm/s range and establishes their insistent
moderate permeability to bind with plasma proteins and to
pierce into the BBB system. The in vitro plasma protein
binding (PPB) affinity ranging from 90.6733 to 99.2126%
empowers their robust binding ability to plasma proteins. The
in vitro Maden Darby Canine kidney (MDCK) cell
Table 7. ADMET Properties of 5a−j
entry
in vivo BBB penetration
(C.brain/C.blood)a




in vitro MDCK cell
permeability(nm/s)d
in vitro plasma protein
binding (%)e toxicityf
5a 1.2749 21.7129 89.5313 191.0100 95.7056 negative
5b 2.5729 21.7217 97.2754 79.4515 99.2126 negative
5c 0.4368 21.7072 89.8057 122.3450 90.6733 negative
5d 0.4900 18.8444 94.9217 27.9760 91.1146 negative
5e 0.6212 21.7231 94.1342 74.8857 96.2773 negative
5f 1.2911 21.4068 96.4950 38.0802 98.2989 negative
5g 0.7318 21.6890 88.5328 186.4370 93.6175 negative
5h 0.4699 21.7074 92.7086 87.8067 93.2263 negative
5i 0.4518 21.6737 86.9710 122.9902 94.1828 negative
5j 0.4560 16.1225 94.4193 29.6239 94.1007 negative
aBBB penetration = [brain]/[blood]. bCaco-2 cells derived from human colon adenocarcinoma, possessing multiple drug transport pathways
through intestinal epithelium. cHIA (human intestinal absorption), the sum of absorption and bioavailability evaluated from ratio of excretion in
urine, bile, and feces. dMDCK cell system is used as a tool for rapid permeability screening. e% of drug that binds to plasma protein. fIn vitro Ames
test by metabolic and nonmetabolic activated TA100 and TA1535 strains collected from rat liver homogenate.
Table 8. Molecular Descriptor Properties of 5a−ja















of H V. Vol. ρ S CLP % ABS
5a 362.37 6 2 2.08 96.64 0 86.30 9 0 25 325.07 1.246 −3.61 2.52 79.23
5b 447.47 5 1 4.24 126.18 0 60.71 9 0 32 400.65 1.275 −3.54 3.19 88.06
5c 369.35 7 2 2.23 93.67 0 99.97 10 0 25 329.66 1.228 −2.81 1.74 74.51
5d 448.25 7 2 3.02 101.3 0 99.97 10 0 26 347.54 1.414 −3.64 2.46 74.51
5e 413.41 8 1 2.01 104.91 0 98.20 12 0 28 372.73 1.180 −3.14 1.95 75.12
5f 420.21 5 1 3.70 93.36 0 70.51 9 0 24 318.91 1.407 −4.24 2.89 84.67
5g 334.31 6 2 1.77 87.14 0 76.50 7 0 23 291.47 1.297 −3.01 1.38 82.60
5h 339.28 7 1 1.51 81.79 0 89.17 7 0 23 286.42 1.323 −3.20 1.45 78.24
5i 341.30 7 7 0.96 84.18 0 99.17 8 0 23 296.05 1.275 −2.21 1.20 74.78
5j 420.20 7 2 1.92 91.80 0 99.37 8 0 24 313.94 1.480 −3.04 1.65 74.72
aMW: molecular weight; HB Don: hydrogen bond donors (n ON); HB Acc: hydrogen bond acceptors (n OH NH); log P: log of octanol to water
partition coefficient; MR: molecular refractivity (cm3/mol); Lip. Vio.: lipinski violations; TPSA: total polar surface area (Å)2; no. of RB: number of
rotatable bonds; Veb. Vio.: Veber violations; no. of “H”: number of hydrophobic atoms; V. Vol.: van der Waals volume; ρ: density (gm/cc); S:
solubility; CLP: clog P; and % ABS: % of absorption.
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permeability readings ranging from 27.9760 to 191.0100 nm/s
discloses them as worthy permeable. In the same way, the
human intestinal absorption (% HIA) in the range of
86.9710−97.2754 ratio promises the interactions of 5a−j
with suitable species of the anticipating target domains. The
negative sign of toxicity properties of 5a−j assures them as
safer and nontoxic drugs. In summary, this analysis has
revealed the physicochemical interactions and druglikeness
properties of 5a−j.
2.6. QSAR Studies. The results obtained from in silico
molecular descriptor properties (Table 8) designates that
compounds 5a−j are designed to obey the properties and their
molecular weights ranging from 334.31 to 448.25 (less than
500 Da) approves the same. Similarly, they have been validated
with log P values in the range of 4.24−0.96 (less than 5)
suggesting their good permeability through cell membranes.
Likewise in the line of Lipinski’s rule of five, the number of
hydrogen bond donors <5 and acceptors <10 are also validated
in all molecules that were synthesized. Similarly, the molecular
refractivity ranging from 81.79 to 126.18 cm3/mol has also
obeyed the valid range, that is, 40−130 cm3/mol.
Hence, ascertained compounds 5a−j are following the
Lipinski rule of five, and all of them are significantly orally
active drugs with worthy druglikeness properties. Furthermore,
the total polar surface area is precised by the total effect of all
polar atoms such as oxygen, nitrogen, and attached hydro-
gens;64 for instance, compounds 5a−j are also in the range of
60.71−99.97 Å2, which are ultimately less than 140 Å2, and are
also satisfying the Veber rule. Henceforth, compounds 5a−j
are assessed as they can be easily diffused, absorbed, and
transported in the systems to which they are exposed. At this
juncture, TPSA is highly interrelated with the hydrogen
bonding of a compound and is accompanied with the transport
properties of that drug across membranes and the correlation
of BBB for the intestinal crossing. Compounds with TPSA
≤160 Å2 have been identified as good intestinal absorption
compounds with BBB penetrability ≤60 Å2 as BBB-penetrable
and CNS-active agents.65 TPSA for the scrutinized sequences
all the offshoots have been identified as the best intestinal
absorbing ones. Similarly, the number of rotatable bonds
among all the compounds is identified with a range of 7−12,
which is according to the Veber rule, and eventually, they are
also obeying the Veber’s rule and established themselves as
orally administrable drugs. Furthermore, the percentage of
absorption in the range of 79.23−88.06, density ranging from
1.246 to 1.480 gm/cc, solubility in the range of −2.21 to
−4.24, van der Waals volume ranging from 286.42 to 400.65
Å3, and clog P ranging from 1.20 to 3.19 establish compounds
5a−j drug-like compounds and are significantly safer. These
properties helped a lot in considering their physicochemical
interactions against the target entities and eventually helped in
deciding the drug potentialities that are associated by the
bioactivity and toxicity risks studies.
The synthesized molecules 5a−j are identified with the
fingerprint properties (Table 9) as having all of them are
having the C1 point group of symmetry elements in them and






















5a C1 −106.66 −4165.36 −31020.65 26855.30 0.98 1.89 64 8.36 −8.36 0.07 375.31 430.50
5b C1 −105.79 −4165.32 −31142.12 26976.79 0.94 1.84 64 8.14 −8.14 0.30 372.69 431.76
5c C1 −209.24 −4489.49 −33075.83 28586.33 0.92 2.49 66 8.79 −8.79 −0.05 370.76 440.94
5d C1 −209.11 −4823.17 −35478.33 30655.16 0.99 2.09 69 8.91 −8.91 −0.24 386.63 463.71
5e C1 −241.18 −5123.82 −40651.74 35527.92 0.90 1.53 75 9.07 −9.0 −0.30 402.91 497.09
5f C1 −167.25 −4487.54 −30712.54 26224.99 0.97 1.97 63 9.17 −9.17 −0.60 365.74 429.05
5g C1 −96.74 −3852.44 −26907.70 23055.26 0.99 1.81 58 8.38 −8.38 0.06 335.01 384.06
5h C1 −187.95 −4147.75 −27663.14 23515.38 0.91 1.84 59 8.86 −8.86 −0.20 330.80 375.71
5i C1 −202.23 −4176.70 −28679.19 24502.48 0.98 2.43 60 8.73 −8.73 0.05 335.26 391.00
5j C1 −199.95 −4510.28 −30781.31 26271.03 0.95 0.82 63 9.09 −9.09 −0.38 357.86 417.55
aH.F.: heat of formation; T.E.: total energy; E.E.: electronic energy; C.C.R: core−core repulsion; G.N.: gradient norm; F.L.: filled levels; I.P.:
ionization potential; H.E.: HOMO energy; L.E.: LUMO energy; C.A.: COSMO area; and C.V.: COSMO volume.
Table 10. Bioactivity Scores, Drug Properties, and Toxicity Risks of 5a−ja
bioactivity drug properties toxicity risks
entry GPCRL ICM KI NRL PI EI drug-likeness drug score Mut Tum Irrit R.E.
5a −0.20 0.14 −0.20 −0.46 0.01 0.11 −32.76 0.42 green green green green
5b −0.24 0.07 −0.27 −0.33 0.02 0.10 −34.08 0.08 green green green green
5c −0.46 0.01 −0.47 −0.51 −0.07 0.02 −33.04 0.43 green green green green
5d −0.64 −0.12 −0.56 −0.68 −0.23 −0.11 −34.72 0.33 green green green green
5e −0.45 −0.04 −0.44 −0.59 −0.09 −0.03 −30.14 0.44 green green green green
5f −0.49 −0.04 −0.46 −0.62 −0.18 −0.08 −38.50 0.34 green green green green
5g −0.21 0.20 −0.29 −0.58 0.01 0.15 −25.33 0.16 green green green green
5h −0.47 −0.01 −0.65 −0.75 −0.06 0.10 −25.97 0.15 green green green green
5i −0.47 0.06 −0.57 −0.61 −0.07 0.06 −25.68 0.16 green green green green
5j −0.66 −0.07 −0.66 −0.79 −0.22 −0.08 −27.42 0.14 green green green green
aGPCRL: G protein-coupled receptor ligand; ICM: ion channel modulator; KI: kinase inhibitor; NRL: nuclear receptor ligand; PI: protease
inhibitor; EI: enzyme inhibitor; Mut: mutagenic; Tum: tumorigenic; Irrit: irritant; R.E.: reproductive effect; green: green color indicates drug-
conform behavior.
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heat of formation is identified within the range of −96.74 to
−241.18 kcal/mol, total energy ranges from −3852.44 to
−5123.82 eV, electronic energy ranges from −26907.7 to
−40651.74 eV, and core−core repulsion energy ranges from
23055.26 to 35527.92 eV. Similarly, the gradient norm is
identified in the ranges of values from 0.90 to 0.99, whereas the
dipole difference is identified with 0.82−2.49 debye. The filled
levels were identified with 58−75 units, and the ionization
potential values are identified from 8.14 to 9.17 eV. Similarly,
highest occupied molecular orbital (HOMO) and lowest
unoccupied molecular orbital (LUMO) energies are identified
from −8.14 to −9.17 eV and from −0.6 to 0.3 eV, respectively.
Similarly, the Cosmo area and Cosmo volumes are identified
within the range of 330.80−402.91 Å2 and 375.71−497.09 Å3,
respectively. All these predicted values confirm that the
synthesized molecules are correlating with the potential limits
of safer drugs and pharmaceuticals, and hence, in comple-
mentary perspectives of the molecular descriptors, they are
obeying the QSAR properties.
2.7. Bioactivity and Toxicity Risk Studies. The study of
bioactivity and toxicity risk properties of 5a−j (Table 10)
inferred the bioactivity properties such as GPCRL (GPCR
ligand property), ICM (ion channel modulator), KI (kinase
inhibitor), NRL (nuclear receptor ligand) interactions, PI
(protease inhibitor) and EI (enzyme inhibitor) interactions,
and drug properties (druglikeness and drug scores), which
have ascertained them as nontoxic and potential molecules.
Prediction of these properties by Molinspiration software had
comprehensively helped to assess the cheminformatics of 5a−j
by relating with in vitro and in vivo results based on functional
group similarity. The results of toxicity risk study supporting
5a−j as safer compounds as they are encompassed with no
risks of tumorigenicity, mutagenicity, irritant and are showing
no effect on the reproductive system and conformed their
drug-like behavior. The positive magnitude of druglikeness
represents most of the fragments that are the part of
commercial drug molecules; however, many compounds
signify the negative magnitudes.66 Another important factor
that infers about the association of a substance from the
administering site to the blood stream is solubility, and good
solubility leads to good absorption.67 Similarly, drug score is
considered as a harmonizing parameter that wholly represents
clog P, druglikeness, log S, toxicity risks, and molecular weight
and accounted to decide the molecule’s inclusive potential to
denote a drug. Eventually, it is identified that all the
synthesized analogues 5a−j showed higher scores (Table 10).
2.8. Structure−Activity Relationship Studies. The
molecular docking studies of 5a−j have well established the
structure−activity relationship for them as molecules were
intensely bound to glutamine (GLN340) located on chain C of
1DNU protein. Specifically, hydrogen bonding with GLN340
is identified as such the oxygen atom of the phosphoryl group
has been strongly bound to the amino hydrogen atom of the
amide bond present on the glutamine and is responsible for the
antioxidant activity.
Similarly, molecules are strongly bound to tyrosine
(TYR597) located on chain A of 4ME7 protein. Specifically,
hydrogen bonding with TYR597 is identified as such the
amino hydrogen atom of the α-aminophosphoryl group has
been strongly bound to the phenolic oxygen atom present on
the tyrosine and is responsible for the antioxidant activity
(Figure 5). Moreover, the oxidative stress comprehends the
pathogenesis of neurodegenerative diseases triggered by the
excess quantity of reactive oxygen species created in vivo by
uneven biochemical disorders and which again causes damage
of neuronal cells and their death.68−71 In relation to this, the
title compounds are identified as good BBB-penetrable
compounds; they can be considered as neuroprotective
antioxidants with CNS-active potentiality as the neuro-
protective property is determined with BBB penetration
thresholds.
3. CONCLUSIONS
Novel α-furfuryl-2-alkylaminophosphonates (5a−j) were
successfully synthesized with the aid of SiO2−I2, an eco-
friendly catalyst. Their antioxidant properties were studied by
DPPH and H2O2 radical scavenging assays. The plant growth
regulatory activity in terms of growth of root length and shoot
length was studied and observed that compounds 5e, 5c, and
5i were identified with potential activity and comparable to the
standards. The additional studies such as ADMET, QSAR,
molecular docking, and bioactivity and toxicity risk have been
well correlating with the results predicted in vitro. The
complementary consideration of all the studies has supported
the synthesized compounds as potential antioxidants and plant
growth regulators with potential CNS-active neuroprotective
antioxidant activity.
4. EXPERIMENTAL SECTION
4.1. General. Chemicals are acquired from Sigma-Aldrich,
solvents were distilled before use, and the reactions were
performed on a CATA-4R (Catalyst System) scientific
microwave instrument. Thin-layer chromatography (TLC)
analysis has been performed on silica gel-G-coated aluminum
sheets as procured from Merck; the analyte mobilities were
visualized under UV light, iodine absorption, and ninhydrin
solution. 1H and 13C NMR and spectral studies were
performed on a Bruker 400 MHz spectrometer, and the
spectra were recorded in deuterated chloroform (CDCl3) by
using tetramethylsilane (TMS) as an internal reference
standard.
Infrared (IR) spectra were recorded on a Bruker Alpa-ECO-
ATR-FTIR (attenuated total reflection Fourier transform
infrared) interferometer by using a single reflection sampling
module equipped with a zinc selenide (ZNSe) crystal, and the
readings were expressed in reciprocals of centimeter (cm−1).
Mass spectra were recorded by using an Agilent-MS
spectrometer.
4.2. Chemistry. Synthesis of aminophosphonates (5a−j)
has been achieved from the reaction of a mixture of carbonyl
derivatives (1.0 mmol), furfurylamine (1 mmol), and diethyl/
dimethyl hydrogen phosphite (1.0 mmol) by using SiO2−I2
(10 mol %) catalyst by irradiating under microwave at 600 W
and 40 °C for 15−25 min. The reaction progress was
scrutinized by TLC for the completion of the reaction and
Figure 5. Structure−activity relationship of 5a−j.
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then 25 mL of ethyl acetate was added to the crude content
and filtered, followed by washing with ethyl acetate (2 × 10
mL). Then, the solvent contents were evaporated by a rotary
evaporation process. The crude compound was purified, and
the pure product was collected by column chromatography
and characterized by spectral and elemental analysis.
4.2.1. Diethyl (((Furan-2-ylmethyl)amino)(1H-indol-3-yl)-
methyl)phosphonate (5a). Brown liquid, 92% yield (334.7
mg); FT-IR (ZnSe): υmax 3215, 2977, 2924, 1444, 1432, 1213,
1019, 953, 734; 1H NMR (400 MHz, CDCl3/TMS): δ 10.08
(br s, 1H), 7.71−7.69(d, JHH = 7.72 Hz, 1H), 7.38−7.7.35 (m,
2H), 7.24 (s, 1H), 7.17−7.08 (m, 2H), 6.29 (s, 1H), 6.09 (s,
1H), 4.46 (d, JHH = 17.4 Hz, 1H), 4.16−4.09 (m, 2H), 4.00−
3.95 (m, 1H), 3.89 (d, JHH = 14.56, 1H). 3.81−3.74 (m, 1H),
3.72−3.68 (d, JHH = 14.56, 1H), 3.19 (br s, 1H), 1.31−1.27 (m,
3H), 1.09−1.05 (m, 3H); 13C NMR (100 MHz, CDCl3/
TMS): δ 153.05, 142.07, 136.49, 126.96, 124.99, 121.79,
119.20, 111.74, 110.20, 108.38, 107.83, 77.39, 76.91, 62.98,
52.10, 50.48, 16.17; HRMS (ESI) m/z calcd for
C18H23N2O4P
+ (M + H), 362.1395; found, 362.1392.
4.2.2. Diethyl (((Furan-2-ylmethyl)amino)(pyren-4-yl)-
methyl)phosphonate (5b). Dark brown liquid, 90% yield
(402.3 mg); FT-IR (ZnSe): υmax 3318, 2981, 2920, 1678,
1234, 1017, 954, 730; 1H NMR (400 MHz, CDCl3): 8.49 (s,
1H), 8.34 (s, 1H), 8.28 (d, J = 7.2 Hz, 1H), 8.20−8.12 (m,
3H), 8.05 (d, J = 9.2 Hz, 2H), 8.02−7.93 (m, 1H), 7.37 (s,
1H), 7.29 (s, 1H), 6.28 (s, 1H), 5.99 (s, 1H), 5.33 (d, J = 19.6
Hz, 1H), 4.17−4.03 (m, 2H), 3.90 (d, J = 14.0 Hz, 2H), 3.70
(dd, J = 15.5, 7.4 Hz, 1H), 3.60 (d, J = 14.7 Hz, 1H), 3.22 (s,
1H), 1.27 (t, J = 6.2 Hz, 3H), 0.99 (t, J = 6.6 Hz, 3H); 13C
NMR (101 MHz, CDCl3): δ 152.80, 142.20, 131.37, 130.97,
130.67, 130.01, 128.90, 127.63, 125.51, 124.80, 124.75, 110.20,
108.12, 77.64, 77.32, 77.01, 63.78, 62.99, 43.70, 34.88, 16.50;
HRMS (ESI) m/z calcd for C26H26NO4P
+ (M + H), 447.1599;
found, 447.1598.
4.2.3. Diethyl (((Furan-2-ylmethyl)amino)(4-hydroxy-3-
methoxyphenyl)methyl)phosphonate (5c). Yellow liquid,
95% yield (349.8 mg), FT-IR (ZnSe): υmax 3184, 2980,
2920, 1514, 1211, 1021, 953, 738; 1H NMR (400 MHz,
CDCl3): δ 7.34 (d, J = 1.0 Hz, 1H), 7.03 (s, 1H), 6.86 (d, J =
2.1 Hz, 2H), 6.32−6.26 (m, 1H), 6.09 (d, J = 2.5 Hz, 1H),
4.08−4.01 (m, 2H), 4.00−3.92 (m, 2H), 3.88 (d, J = 3.2 Hz,
3H), 3.87−3.83 (m, 1H), 3.82−3.76 (m, 1H), 3.56 (d, J = 14.6
Hz, 1H), 1.27 (t, J = 7.1 Hz, 3H), 1.17 (t, J = 7.1 Hz, 3H); 13C
NMR (101 MHz, CDCl3): δ 152.84, 146.98, 145.75, 142.01,
126.34, 122.03, 114.45, 111.07, 110.09, 107.73, 77.41, 77.09,
76.77, 62.94, 59.59, 58.04, 55.95, 43.49, 16.32; HRMS (ESI)
m/z calcd for C17H24NO6P
+ (M + H), 369.1341; found,
362.1344.
4.2.4. Diethyl ((3-Bromo-4-hydroxy-5-methoxyphenyl)
((Furan-2 ylmethyl)amino) methyl) Phosphonate (5d).
Orange red liquid, 89% yield (398.7 mg), FT-IR (ZnSe):
υmax 3125, 2980, 1495, 1424, 1278, 1231, 1156, 1026, 728;
1H
NMR (400 MHz, CDCl3): δ 9.73 (s, 1H), 7.35 (d, J = 1.3 Hz,
2H), 7.12 (d, J = 1.9 Hz, 2H), 6.99 (d, J = 1.8 Hz, 2H), 6.30
(d, J = 1.7 Hz, 2H), 6.10 (s, 2H), 4.11−3.95 (m, 8H), 3.89 (d,
J = 2.0 Hz, 10H), 3.80 (d, J = 15.0 Hz, 2H), 3.56 (d, J = 14.7
Hz, 2H), 3.04−2.94 (m, 2H), 1.27 (t, J = 8.9 Hz, 6H), 1.21 (t,
J = 8.1 Hz, 6H); 13C NMR (101 MHz, CDCl3): δ 155.58,
150.54, 146.09, 145.12, 113.16, 110.89, 80.44, 80.12, 79.80,
66.34, 65.89, 62.25, 60.71, 59.43, 46.47, 19.38, 11.57; HRMS
(ESI) m/z calcd for C17H23BrNO6P
+ (M + H), 447.0446;
found, 447.0448.
4.2.5. Diethyl (((Furan-2-ylmethyl)amino)(3,4,5-
trimethoxyphenyl)methyl)phosphonate (5e). Pale yellow
liquid, 96% yield (396.6 mg); FT-IR (ZnSe): υmax 3216,
2991, 2933, 1524, 1221, 1037, 956, 735; 1H NMR (400 MHz,
CDCl3): δ 7.33 (s, 2H), 6.67 (d, J = 2.2 Hz, 3H), 6.28 (d, J =
2.4 Hz, 2H), 6.09 (d, J = 3.3 Hz, 2H), 4.10−3.95 (m, 8H),
3.95−3.90 (m, 3H), 3.90−3.81 (m, 20H), 3.78 (s, 2H), 1.26 (t,
J = 7.1 Hz, 7H), 1.18 (t, J = 7.0 Hz, 7H); 13C NMR (100
MHz, CDCl3): δ 153.19, 152.78, 142.03, 130.59, 110.10,
107.75, 105.67, 99.99, 77.43, 77.12, 76.80, 62.92, 60.81, 60.13,
58.59, 56.13, 43.50, 16.26; HRMS (ESI) m/z calcd for
C19H28NO7P
+ (M + H), 413.1603; found, 413.1601.
4.2.6. Diethyl ((5-Bromo-2-fluorophenyl)((furan-2-
ylmethyl)amino)methyl)phosphonate (5f). Orange red
liquid, 85% yield (357.2 mg); FT-IR (ZnSe): υmax 3306,
2982, 1477, 1237, 1021, 958, 805, 731; 1H NMR (400 MHz,
CDCl3): δ 7.73−7.69 (m, 1H), 7.33 (ddt, J = 8.9, 4.5, 2.3 Hz,
1H), 7.29 (d, J = 1.7 Hz, 1H), 6.90 (t, J = 9.1 Hz, 1H), 6.22
(dd, J = 3.1, 1.9 Hz, 1H), 6.07 (d, J = 3.1 Hz, 1H), 4.38 (d, J =
20.3 Hz, 1H), 4.13−4.04 (m, 2H), 3.98 (ddd, J = 12.6, 7.7, 5.8
Hz, 2H), 3.76 (d, J = 14.6 Hz, 1H), 3.55 (d, J = 14.6 Hz, 1H),
1.25 (t, J = 7.1 Hz, 3H), 1.16 (t, J = 7.1 Hz, 3H); 13C NMR
(100 MHz, CDCl3): δ 161.38, 158.91, 152.21, 142.13, 132.26,
125.63, 117.00, 110.12, 107.91, 99.99, 77.50, 77.18, 76.86,
63.06, 51.97, 50.40, 43.97, 16.20; HRMS (ESI) m/z calcd for
C16H20BrFNO4P
+ (M + H), 419.0297; found, 419.0296.
4.2.7. Dimethyl (((Furan-2-ylmethyl)amino)(1H-indol-3-
yl)methyl)phosphonate (5g). Orange yellow solid, 90% yield
(301 mg); FT-IR (ZnSe): υmax 3168, 2923, 2852, 1646, 1449,
1185, 1037, 731, 1H NMR (400 MHz, CDCl3): δ 9.49 (d, J =
23.7 Hz, 1H), 7.69−7.60 (m, 1H), 7.42−7.35 (m, 2H), 7.24−
7.10 (m, 3H), 6.38−6.22 (m, 2H), 6.10 (d, J = 3.2 Hz, 1H),
4.47 (d, J = 17.4 Hz, 1H), 3.96 (d, J = 10.5 Hz, 1H), 3.76 (d, J
= 10.5 Hz, 3H), 3.53 (d, J = 10.4 Hz, 3H); 13C NMR (101
MHz, CDCl3): δ 152.95, 142.04, 136.33, 126.85, 122.10,
119.71, 119.13, 118.66, 111.66, 110.15, 108.69, 107.85, 104.25,
100.00, 77.40, 77.09, 76.77, 53.46, 43.61; HRMS (ESI) m/z
calcd for C16H19N2O4P
+ (M + H), 334.1082; found, 334.1078.
4.2.8. Dimethyl (benzo[d][1,3]dioxol-5-yl((furan-2-
ylmethyl)amino)methyl)phosphonate (5h). Pale yellow
solid, 83% yield (281.7 mg); FT-IR (ZnSe): υmax 3218,
2945, 1620, 1232, 1025, 820, 746; 1H NMR (400 MHz,
CDCl3): δ 7.24 (d, J = 5.9 Hz, 2H), 6.85 (d, J = 1.5 Hz, 2H),
6.71 (dd, J = 20.1, 12.2 Hz, 4H), 6.14 (d, J = 1.8 Hz, 2H), 5.98
(t, J = 9.9 Hz, 2H), 5.79 (s, 4H), 4.86 (d, J = 87.0 Hz, 1H),
3.85 (d, J = 19.0 Hz, 2H), 3.58 (s, 6H), 3.47 (s, 6H); 13C NMR
(100 MHz, CDCl3): δ 152.57, 147.92, 147.44, 141.99, 128.49,
122.28, 110.04, 108.62, 108.15, 107.68, 101.11, 59.08, 57.53,
53.42, 43.10; HRMS (ESI) m/z calcd for C14H18NO6P
+ (M +
H), 339.0872; found, 339.0874.
4.2.9. Dimethyl (((Furan-2-ylmethyl)amino)(4-hydroxy-3-
methoxyphenyl)methyl)phosphonate (5i). Yellow solid, 93%
yield (317.2 mg); FT-IR (ZnSe): υmax 3428, 3168, 2942, 1693,
1497, 1178, 1032, 732; 1H NMR (400 MHz, CDCl3): δ 7.28
(d, J = 4.6 Hz, 2H), 7.04 (s, 1H), 6.93 (s, 1H), 6.22 (d, J = 1.3
Hz, 1H), 6.04 (s, 1H), 3.90 (d, J = 18.9 Hz, 1H), 3.79 (s, 3H),
3.74 (d, J = 14.5 Hz, 2H), 3.67 (d, J = 10.6 Hz, 3H), 3.55 (d, J
= 10.5 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 152.31,
147.92, 143.47, 142.14, 126.81, 124.91, 110.15, 108.57, 107.97,
58.69, 57.13, 56.35, 53.80, 53.65, 43.37; HRMS (ESI) m/z
calcd for C15H20NO6P
+ (M + H), 341.1028; found, 341.1026.
4.2.10. Dimethyl((3-bromo-4-hydroxy-5-methoxyphenyl)-
((furan-2-ylmethyl)amino)methyl)phosphonate (5j). Orange
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red solid, 85% yield (357.1 mg); FT-IR (ZnSe): υmax 3373,
3113, 2949, 1603, 1515, 1455, 1203, 1029, 743; 1H NMR (400
MHz, CDCl3): δ 7.24 (d, J = 7.6 Hz, 1H), 6.92 (s, 1H), 6.83−
6.68 (m, 2H), 6.17 (d, J = 5.1 Hz, 1H), 6.00 (d, J = 4.9 Hz,
1H), 3.90 (dd, J = 18.6, 7.3 Hz, 1H), 3.76−3.33 (m, 11H), 13C
NMR (100 MHz, CDCl3): δ 152.55, 147.49, 146.23, 142.02,
125.49, 121.76, 121.70, 115.01, 111.28, 110.07, 107.79, 77.72,
77.41, 77.05, 59.00, 57.45, 55.80, 53.66, 43.08; HRMS (ESI)
m/z calcd for C15H19BrNO6P
+ (M + H), 419.0133; found,
419.0131.
4.3. Antioxidant Activity. 4.3.1. DPPH Radical Scaveng-
ing Activity. In practice, the electron donation capacity or
hydrogen atom donation ability of a compound is confirmed
from the bleaching ability of purple color of methanolic DPPH
solution to colorless. In this spectrophotometric study, 1 mL of
the test sample of compounds that are to be screened for
antioxidant activity with different concentrations (50, 100, and
200μg/mL) was prepared and added to 4 mL of 0.004% (w/v)
methanolic DPPH solutions.72−76 Then, the analytical mixture
was mixed thoroughly for 1 min and then incubated at room
temperature for a period of 30 min. After completion of
incubation process, the absorbance of all the test samples was
measured at 517 nm and was referenced to ascorbic acid
reference standards. Finally, DPPH radical scavenging activity











4.3.2. H2O2 Radical Scavenging Activity. To the 1 mL test
solution of different concentrations (50, 100, and 200 μg/mL)
of the synthesized compounds of the study were added with
3.75 mM of deoxyribose, 1.0 mM of H2O2, 20 mM of
potassium phosphate buffer (7.4 pH), 0.1 mM of FeCl3, and
0.1 mM of EDTA and incubated for a period of 1 h at 37 °C
temperature in a water bath. The degree of degradation of
deoxyribose was measured by adding thiobarbituric acid
(1.0%) and trichloroacetic acid (2.0%) and heating them in
a water bath at 100 °C for a period of 20 min. Eventually, the
absorbance of the resulting test solutions was obtained











4.4. Plant Growth Regulatory Activity. Seeds were
germinated at 25 °C for 48 h in 12 h light and 12 h darkness.
Groups of 50 uniform well-sterilized seedlings were transferred
to 10 cm Petri dishes that are outlined with two discs of
Whatman no. 1 filter paper wetted with 2 mL of 0.001M
aqueous methanol (control) and 2 mL of solutions of the test
compounds (5a−j) at 50 and 100 ppm concentrations. The
plants were grown in simultaneous 16 h light and 8 h dark
conditions at 25 ± 2 °C for 48 h and the lengths of roots and
stem were measured. The results are presented as the average
increase or decrease in root length and shoot length compared
with the control. Each experiment was repeated three times.
4.5. Molecular Docking Studies. The mechanistic
inhibition of propagating DPPH and H2O2 free radicals in
vivo by title compounds 5a−j has been determined by studying
the molecular docking interactions. As such, the three-
dimensional crystalline structural information of identified
proteins of the study were attained from protein data bank (as
pdb files) and reinvigorated them by removing bound water,
ligands, and other cofactors present in their vicinity. The .mol2
and .pdb database files of 5a−j ligands were produced from
ChemBioOffice software (ChemBio3D ultra 14.0 suite) and
docked them for the selected proteins on Swiss Dock
software.77 The interactive docking poses were considered
and captured at energy-minimized optimization conditions
with 0.100 of minimum root-mean standard deviation
(RMSD) gradient and the interacting binding postures are
imagined through UCSF Chimera.78 The potential and highest
binding energies originated with proper ligand−protein
interactions of 5a−j with target protein receptors in chain C
of 1DNU protein and chain A of 4M7E protein, respectively,
for the antioxidant and plant growth regulatory activities and
were accounted in macromolecular structural atmosphere and
acknowledged that compounds 5a−j as efficiently bound with
the proteins considered for the study and presented in Tables
3−6.
4.6. ADMET Properties. The ADMET properties of
synthesized compounds 5a−j have been calculated on
preADMET online server79,80 and which assisted us to
understand their potentialities like in vivo BBB penetration,
% HIA, in vitro Caco-2 cell permeability, in vitro Maden Darby
Canine kidney (MDCK) cell permeability, and in vitro PPB
properties. In continuance, the prediction of tumorigenic,
mutagenic, reproductive, and irritant effects has assisted in
ascertaining the toxicity properties. The BBB is confined with
profoundly bound endothelial cells that constrain a com-
pound’s ability to be conceded into the blood stream via the
directed route. The analysis of BBB penetration rate (in terms
of concentration ration, i.e., [brain]/[blood]) supported us to
inspect the ability of an entity to penetrate over BBB, which is
dynamic in assigning CNS activity to the libraries of
pharmacophoric assets of a compound. The compounds
proficient to pass via BBB are denoted as CNS active
(where, BBB penetration rate >0.40) and unable to pass are
denoted as CNS inactive (where, BBB penetration rate <
0.40). Similarly, Caco-2 (human colon adenocarcinoma based
cells) cells associates by an intestinal epithelium system in
multiple drug transport avenues such as transcellular, para-
cellular, and active efflux transports. The compounds with in
vitro Caco-2 cell permeability value <4 are assigned as poor,
the permeability in the range of 4−70 is assigned as moderate,
and permeability value >70 is assigned as extremely permeable
and are efficiently transported to biochemical and cellular
processes. Moreover, the extent of PPB influences distribution
level of unbound quantity of compound in body tissues and
distributed over cellular sites of action and hence stimulates to
metabolize and excrete from systems. The % PPB in vitro
classifies the compounds as strong if % PPB > 90% and as weak
if % PPB < 90%, which eventually reflects its potentiality.
Moreover, the MDCK cell system is recognized as a sensible
system to filter out the prompt permeability of a compound
and to decide its potentiality as cellular life span is lower than
the life span of Caco-2 cells and therefore the correspondence
stands high. Mostly, in vitroMDCK permeability <25 describes
compound as poorly permeable, permeability in the range of
25−500 designated as sensibly permeable, and permeability
>500 designated as greatly permeable. Likewise, the % HIA is
deliberated as the percentage of an orally administered drug
compound into the hepatic portal vein. Generally, it is
accounted for ample bioavailability and absorption measured
based on the ratio of cumulative excretion in bile, urine, and
feces. The % HIA ranging from 0 to 20 entitles poor, 20−70
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entitles moderate, and 70−100 entitles good absorbance of a
compound under study. Coming to the toxicology perspec-
tives, it is important to consider the toxicology properties of an
entity under study so as to ignore the toxicity risks during the
design itself. The negative magnitude of toxicology for a
compound is the outcome of its safer drug property as they are
reclining to carcinogenicity, mutagenicity, and HERG (human
ether-a-go-go related gene) channel inhibition and its
administration in vivo as presented in Table 7. This type of
complementary study ascertains a chemical entity as safer
drugs.
4.7. QSAR Studies. Many proposed drugs do not come to
the clinical stage because of their poor ADMET liabilities, but
the worthy oral bioavailability can be realized them by right
poise amidst its partition and solubility.81 Computationally,
Lipinski’s rule of five82 is considered for screening newer
molecules to testify their potentiality as it states that (i)
molecular weight ≤ 500 Da; (ii) octanol/water partition
coefficient (log P) ≤ 5; (iv) number of hydrogen bond donors
≤ 5; and (iii) number of hydrogen bond acceptors ≤ 10 and
summarizes the Lipinski parameters (molecular weight,
hydrogen bond acceptors, hydrogen bond donors, molecular
refractivity, and octanol to water partition coefficient). The
drug-like properties predicted by Molinspiration83 are very
sturdy and work on the summation of fragment contributions
and handling most of the organic compounds to compute and
to know the structural sensitivity in visualizing the significant
molecular properties like Veber parameters (number of
rotatable bonds and total polar surface area in addition to
Lipinski parameters) and other parameters like number of
hydrophobic atoms; van der Waals volume, density, solubility,
calculated octanol to water partition coefficient and percentage
of absorption) has been considered and all the quantitative
structure−activity relationship descriptors were obtained and
presented in Table 8.
In this QSAR analysis study, molecular descriptors and
fingerprints both play an important role as they are
mathematical representations of chemical entities and serves
as the data analysis methodological input sources in building
QSAR models.84−86 In detail, molecular descriptors are the
experimental results of a molecule according to their
theoretically derived properties, which helps in understanding
the molecular structure and biological activity of the
compounds under study from different facets.87−89 In
complementary molecular descriptors and fingerprint proper-
ties, both portray a vital role in QSAR analysis and in turn in
the drug discovery process.90−93 The fingerprint properties of
5a−j have been predicted from the ChemDes server,94,95 an
integrated aid for the computing the results. Here, the QSAR
results were predicted in MOPAC Cartesian format, a
semiempirical molecular orbital package to scrutinize molec-
ular structures and is widely accepted for the prediction of
QSAR and other drug discovery studies. These computational
chemical studies were performed by modified neglect of
diatomic overlap, a semiempirical approach for calculating
molecular electronic structural quantum, which is designed on
neglect of diatomic differential overlap integral approximation
process and the results are presented in Table 9.
4.8. Bioactivity and Toxicity Risk Studies. The drug-like
property profiles of compounds 5a−j have been assessed on
Molinspiration cheminformatics software tool,66 viz., v2018.10
Molinspiration engine for property exploration and v2018.03
Molinspiration engine for bioactivity score evaluations. This
evaluation revealed the bioactivity and nontoxic properties
such as KI (kinase inhibitor), GPCR (G protein-coupled
receptor) ligand property, ICM (ion channel modulator), and
NRL (nuclear receptor ligand) interactions, and EI (enzyme
inhibitor) and PI (protease inhibitor) properties, drug-likeness,
and drug scores and mutagenic, tumorigenic, irritant, and
reproductive effect of the synthesized compounds have been
evaluated and proved as safer drugs. On the other hand, drug
properties mounted with the multifarious offset of a set of
structural features and molecular properties, and its evaluation
helps to evaluate the close approximation of a molecule under
investigation with the notorious drugs. Hence, these toxicity
risk profiles and drug property parameters have predicted by
the Osiris online property explorer toolkit69 and consolidated
the properties under the head of bioactivity and toxicity risk
studies and are presented in Table 10. This study helped in
considering the physicochemical interactions of the synthe-
sized compounds against the targeted domains and eventually
facilitated for determining corresponding drug properties by
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